Berlin, 22 February 2023 – Raue is expanding its corporate and transactional team with the addition of Dr. Nadine Hartung as an equity partner on 1 March 2023. Dr. Nadine Hartung specializes in corpo-rate and M&A advice in the healthcare sector and was previously a partner with McDermott Will & Emery in Munich.
Dr. Nadine Hartung advises national and international investors and healthcare providers on corporate law, M&A transactions, contract drafting, corporate governance and compliance issues. Her clients include private equity and venture capital funds, medical care centres (MVZ), operators of hospitals and nursing homes as well as pharmaceutical companies and medical product manufacturers. She is recommended by Legal 500, Best Lawyers and Handelsblatt.
Dr. Nadine Hartung studied law in Marburg. From 2010 to 2016, she worked with Hengeler Mueller in Berlin and Frankfurt am Main before joining McDermott Will & Emery LLP in 2016. In 2013/2014, she spent a secondment in the M&A team of Cravath, Swaine & Moore in New York.
Dr. Hartung explains the reasons for her move to Raue: “Raue offers numerous synergies with my advisory practice, especially in corporate law and VC advice as well as in health law and the digital economy. I am looking forward to working with my colleagues at Raue to further expand the transac-tion advisory practice, especially in the healthcare sector.”
Dr. Wolfram Hertel, Managing Partner of Raue: “We are very pleased that Nadine Hartung has joined us. In her, we have found an experienced partner personality who has developed an industry-focused advisory offering. This fits perfectly with our own strategic approach. We continue to focus on growth in advising regulated industries and technologies.”
Prof. Dr. Andreas Nelle, partner in Raue’s corporate and M&A practice, comments on Dr. Hartung’s entry: “Nadine Hartung is an excellent addition to our private equity / venture capital practice. With her, we will further increase our expertise in advising on transactions, in particular for national and international investors in the healthcare industry.”
Dr. Katharina Wodarz, partner at Raue in the healthcare sector, adds: “Dr Nadine Hartung is an al-most ideal addition for us. She has known the health sector for many years and is familiar with its complex regulation. This will allow us to advice on new business models and transactions with seam-less integration our strong regulatory team.”
With the arrival of Dr. Nadine Hartung, Raue’s Corporate/M&A, PE/VC practice comprises a total of 14 professionals (six equity partners, one counsel, one senior associate, one of counsel and five as-sociates).